June 27, 2017

Cannabis could be even better at treating migraines than traditionally recommended medications, a new study has found. Researchers from the Interuniversity Center in Florence, Italy found that pills containing both THC and CBD reduced migraine pain by 43.5 percent. Administration of the drug also led to numerous other benefits, including curbing stomach-aches and muscle pain. […]

Ottawa, ON – ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) announced that it has amended and extended the research contract currently in place between its Canadian operating subsidiary, ABcann Medicinals Inc., and the University of Guelph, of Guelph, Ontario. The agreement, which dates back to Jan. 1, 2015, has been extended to Dec. 31, […]

A new research study in Vancouver is looking for 1,000 dispensary clients to participate in an online survey to help inform the government ahead of legalization. The B.C. Centre on Substance Use (BCCSU) is examining the benefits and potential harms of dispensaries, ahead of the July 2018 legalization deadline set out by the feds. “We […]

The article states: “The companies are targeting more than 100 million Americans who suffer from chronic pain, and are dependent on opioid painkillers such as Vicodin, or addicted to street opiates including heroin.”  “We are grateful that Reuters is covering companies like AXIM that are developing alternatives for the roughly 2.5 million Americans addicted to […]

Late last week, two new studies received a flurry of news coverage and at first blush appeared contradictory: An insurance-industry nonprofit found that collision claims had increased in states that legalized marijuana compared to others, while a paper published in an academic journal found no link between legalization and traffic fatalities. Both fueled a now-predictable […]

Maryland medical marijuana regulators took steps Monday to deny a license to one of the 15 companies picked to grow the drug, saying there was a “reasonable likelihood” the firm would not properly safeguard the medicine. In voting to tell MaryMed LLC that it would not receive a final license, the Maryland Medical Cannabis Commission […]